Fig. 6.

Serum ferritin as a surrogate marker of final outcome among patients with macrophage activation-like syndrome (MALS). a Serum levels on days 1 and 3 among 10-day survivors and non-survivors of MALS. b Serum levels on days 1 and 3 among 10-day survivors and non-survivors without MALS. c ROC curve of the % change of serum ferritin between days 1 and 3 as prognostic of death after 10 days among patients with MALS. AUC area under the curve. d 10-day mortality of patients with MALS with more than or less than 15% ferritin decrease between days 1 and 3. p values are provided. CI confidence interval, OR odds ratio